Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41039 

1https://www.whitehouse.gov/sites/ 

whitehouse.gov/files/omb/assets/inforeg/PRA_Gen_

ICRs_5-28-2010.pdf. 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued 

Form Number of 

respondents 

Total 

burden hours 

Average 

hourly 

wage rate *

Total cost 

PSO Certification for Continued Listing Form ................................................. 42 336 40.21 13,510.56 

PSO Two Bona Fide Contracts Requirement Form ........................................ 451 451 40.21 2,050.71 

PSO Disclosure Statement Form .................................................................... 2 6 40.21 241.26 

PSO Profile Form ............................................................................................ 72 216 40.21 8,685.36 

PSO Change of Listing Form .......................................................................... 54 4.50 40.21 180.95 

PSO Voluntary Relinquishment Form .............................................................. 4 2 40.21 80.42 

OCR Patient Safety Confidentiality Complaint Form ....................................... 1 .33 40.21 13.27 

Common Formats ............................................................................................ 1,000 100,000 40.21 4,021,000.00 

Total .......................................................................................................... ........................ ........................ ........................ 4,053,000.33 

*Based upon the mean of the hourly average wages for healthcare practitioner and technical occupations, 29–0000, National Compensation 

Survey, May 2019, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ https://www.bls.gov/oes/current/oes290000.htm. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: July 27, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–16326 Filed 7–29–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10398 #72] 

Medicaid and Children’s Health 

Insurance Program (CHIP) Generic 

Information Collection Activities: 

Proposed Collection; Comment 

Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: On May 28, 2010, the Office 

of Management and Budget (OMB) 

issued Paperwork Reduction Act (PRA) 

guidance 1 related to the ‘‘generic’’ 

clearance process. Generally, this is an 

expedited process by which agencies 

may obtain OMB’s approval of 

collection of information requests that 

are ‘‘usually voluntary, low-burden, and 

uncontroversial collections,’’ do not 

raise any substantive or policy issues, 

and do not require policy or 

methodological review. The process 

requires the submission of an 

overarching plan that defines the scope 

of the individual collections that would 

fall under its umbrella. On October 23, 

2011, OMB approved our initial request 

to use the generic clearance process 

under control number 0938–1148 

(CMS–10398). It was last approved on 

April 26, 2021, via the standard PRA 

process which included the publication 

of 60- and 30-day Federal Register 

notices. The scope of the April 2021 

umbrella accounts for Medicaid and 

CHIP State plan amendments, waivers, 

demonstrations, and reporting. This 

Federal Register notice seeks public 

comment on one or more of our 

collection of information requests that 

we believe are generic and fall within 

the scope of the umbrella. Interested 

persons are invited to submit comments 

regarding our burden estimates or any 

other aspect of this collection of 

information, including: The necessity 

and utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

August 13, 2021. 

ADDRESSES: When commenting, please 

reference the applicable form number 

(see below) and the OMB control 

number (0938–1148). To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may access CMS’ 

website at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Following 

is a summary of the use and burden 

associated with the subject information 

collection(s). More detailed information 


lotter on DSK11XQN23PROD with NOTICES1
41040 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

can be found in the collection’s 

supporting statement and associated 

materials (see ADDRESSES). 

Generic Information Collection 

1. Type of Information Collection 

Request: New collection: Title of 

Information Collection: Expressions of 

Interest in the Infant Well-Child Visit 

Affinity Group; Use: To improve the use 

and quality of well-child visits for 

Medicaid and CHIP beneficiaries ages 0 

to 12 months, CMS has launched the 

Infant Well-Child Visit Learning 

Collaborative Affinity Group. The 

affinity group will provide technical 

assistance to state Medicaid and CHIP 

agencies and their partners through 

group workshops and one-on-one 

meetings. Quality improvement (QI) 

advisors and subject matter experts will 

provide state teams with individualized 

guidance, including QI tools, to identify, 

implement, and test change ideas to 

improve infant well-child visits and 

then scale those changes that prove 

successful. 

Many infants do not receive the 

recommended number of infant wellchild visits. Reasons for missing visits 

include lack of transportation, work 

responsibilities, lack of childcare, and 

other social stressors. The COVID–19 

pandemic has exacerbated the number 

of missed well-child visits, with 21 

percent fewer (4.6 million) child 

screening services provided between 

March through October 2020, compared 

to the same period in 2019. Because 

Medicaid and CHIP cover nearly 40 

percent of all children, focusing on 

well-child visits is an opportunity for 

state Medicaid and CHIP programs to 

improve overall attendance and quality 

of infant well-child visits and to reduce 

disparities in well-infant care. When 

children receive the recommended 

number of high-quality visits, they are 

more likely to be up-to-date on 

immunizations, have developmental 

concerns recognized early, and are less 

likely to visit the emergency 

department. Form Number: CMS–10398 

(#72) (OMB control number: 0938– 

1148); Frequency: Once; Affected 

Public: State, Local, or Tribal 

Governments; Number of Respondents: 

56; Total Annual Responses: 20; Total 

Annual Hours: 140. (For policy 

questions regarding this collection 

contact Kristen Zycherman at 410–786– 

6974.) 

Dated: July 26, 2021. 

William N. Parham, III 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–16208 Filed 7–29–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3410–N] 

Medicare Program; Virtual Meeting of 

the Medicare Evidence Development 

and Coverage Advisory Committee— 

September 22, 2021 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces a 

virtual public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) will be held on 

Wednesday, September 22, 2021. The 

MEDCAC panel will examine relevant 

health outcomes in studies for 

cerebrovascular disease treatment with a 

particular focus on new technologies of 

interest to CMS. Given the increased 

emphasis on new and innovative 

medical products for treating diseases 

that have few proven therapies, studies 

on certain medical technologies have 

focused on intermediate and surrogate 

outcomes rather than longer-term data. 

As a result, there are more frequent 

evidence gaps with respect to the 

clinically meaningful health outcomes 

for CMS beneficiaries, and these gaps 

impact our assessments of medical 

technologies. The MEDCAC panel will 

examine the growing challenges 

associated with the decreased level of 

evidence of certain new and innovative 

technologies. By voting on specific 

questions, and by their discussions, 

MEDCAC panel members will advise 

CMS about the ideal health outcomes in 

research studies of cerebrovascular 

disease treatment technologies, 

appropriate measurement instruments 

and follow-up durations to help to 

provide clarity and transparency of 

National Coverage Analyses (NCAs). 

This meeting is open to the public in 

accordance with the Federal Advisory 

Committee Act. 

DATES: 

Meeting Date: The virtual meeting 

will be held on Wednesday, September 

22, 2021 from 8:00 a.m. until 4:30 p.m., 

Eastern Daylight Time (EDT). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the email address specified 

in the ADDRESSES section of this notice 

by 5:00 p.m., Eastern Daylight Time 

(EDT), on Monday, August 23, 2021. 

Once submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation is 5:00 

p.m., EDT, on Monday, August 23, 2021. 

Speakers may register by phone or via 

email by contacting the person listed in 

the FOR FURTHER INFORMATION CONTACT

section of this notice. Presentation 

materials must be received at the email 

address specified in the ADDRESSES

section of this notice. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via 

email to MedCACpresentations@

cms.hhs.gov section of this notice by 

Monday, August 23, 2021. 

Deadline for All Other Attendees 

Registration: Individuals who want to 

join the meeting may register online at 

https://cms.zoomgov.com/webinar/ 

register/WN_

eJmuvv1UTImALOSXqhKmPQ 4:30 

p.m. EDT, on Wednesday, September 

22, 2021. 

Webinar and Teleconference Meeting 

Information: Teleconference dial-in 

instructions, and related webinar details 

will be posted on the meeting agenda, 

which will be available on the CMS 

website http://www.cms.gov/medicarecoverage-database/indexes/medcacmeetings-index.aspx?bc=

BAAAAAAAAAAA&. Participants in 

the MEDCAC meeting will require the 

following: A computer, laptop or 

smartphone where the Zoom 

application needs to be downloaded; a 

strong Wi-Fi or an internet connection 

and access to use Chrome or Firefox 

web browser and a webcam if the 

meeting participant is scheduled to 

speak or make a presentation during the 

meeting. 

Deadline for Submitting a Request for 

Special Accommodations: Individuals 

viewing or listening to the meeting who 

are hearing or visually impaired and 

have special requirements, or a 

condition that requires special 

assistance, should send an email to the 

MEDCAC Coordinator as specified in 

the FOR FURTHER INFORMATION CONTACT

section of this notice no later than 5:00 

p.m., EDT on Friday, August 27, 2021. 


lotter on DSK11XQN23PROD with NOTICES1